Mar 9, 2021 at 6:50AM
Cronos Group (NASDAQ:CRON) released its fourth-quarter results on Feb. 26 for the period ending Dec. 31, 2020. The cannabis producer had some mixed results; it generated sales growth, but losses continued to mount. And down 21% over the past month, investors have been bearish on the stock it has performed worse than the
Horizons Marijuana Life Sciences ETF, which has fallen by 14% during that time.
But before you decide whether to buy the pot stock on the dip, it s important to take a closer look at the earnings report to see just how well the business is doing. Here are the five of the most surprising numbers from Cronos recent results.